Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen
Clinical trial NCT00135382 · COMPLETED
Trial details
- NCT number
- NCT00135382
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2005-10-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.